| 8.18 0.04 (0.49%) | 05-06 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.57 |
1-year : | 11.18 |
| Resists | First : | 8.19 |
Second : | 9.57 |
| Pivot price | 7.76 |
|||
| Supports | First : | 7.14 |
Second : | 6.49 |
| MAs | MA(5) : | 8.07 |
MA(20) : | 7.64 |
| MA(100) : | 6.71 |
MA(250) : | 6.59 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 96.7 |
D(3) : | 94.6 |
| RSI | RSI(14): 74.3 |
|||
| 52-week | High : | 8.19 | Low : | 5.77 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BTX ] has closed below upper band by 13.8%. Bollinger Bands are 86.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 19 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 8.2 - 8.23 | 8.23 - 8.26 |
| Low: | 8 - 8.03 | 8.03 - 8.06 |
| Close: | 8.13 - 8.17 | 8.17 - 8.22 |
BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.
Mon, 04 May 2026
Wolverine Asset Management LLC Raises Stake in BlackRock Tchnlgy nd Prvt Eqty Trm Trst $BTX - MarketBeat
Tue, 21 Apr 2026
BTX: A Strategy Reset, A 17% Discount, And Retail Access To Frontier AI - Seeking Alpha
Mon, 13 Apr 2026
BlackRock Tchnlgy nd Prvt Eqty Trm Trst (NYSE:BTX) Declares Monthly Dividend of $0.05 - MarketBeat
Mon, 13 Apr 2026
BlackRock Technology And Private Equity Trust (NYSE:BTX) Sector Exposure Guide - Kalkine Media
Sat, 28 Feb 2026
BlackRock’s BTX Reboot Left Investors With A Bigger Discount - Finimize
Fri, 13 Feb 2026
BTX Benefited from an Overweight Position in Tower Semiconductor (TSEM) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 117 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 24.1 (%) |
| Shares Short | 210 (K) |
| Shares Short P.Month | 29 (K) |
| EPS | 0.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 22.1 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |